Back to News
Market Impact: 0.05

Premier Scott Moe unveils new plan for health care in Saskatchewan

Healthcare & BiotechElections & Domestic PoliticsRegulation & Legislation

Premier Scott Moe unveiled the 'Patients First Health Care Plan' targeting the completion of 450,000 surgeries over four years, a three-month surgical wait-time by 2028, and access to diagnostics within 60 days. The plan lists 50+ actions including universal attachment to a primary care provider via expanded virtual care, expanded scopes of practice for health professionals, and increased recruitment/training of doctors, nurses and nurse practitioners. The announcement signals a policy push to increase healthcare capacity and access but is largely operational and political, with limited immediate market impact.

Analysis

The provincial blueprint creates a predictable, multi-year procurement and capacity buildout window that favours scalable digital platforms, staffing vendors, and capital equipment suppliers over one-off service providers. Virtual triage and broader scopes of practice change the flow of care: more cases will be managed upstream by non-physician clinicians or remotely, compressing low-acuity specialist visits while increasing downstream demand for bundled diagnostics and block-time in operating rooms. Expect per-patient touchpoints to shift materially within 12–36 months rather than overnight. Second-order winners are firms that monetize routinized workflows (EMR/telehealth vendors, repeatable imaging and lab services, locum/nurse staffing firms) because they capture recurring revenue from onboarding and scale; device OEMs with strong hospital contracting footprints win if provinces fund OR capacity. Conversationally, the policy also raises the probability of shadow privatization: if targets slip, regulators may relax public-only constraints, creating an asymmetric upside for private clinic operators and private insurers within a 6–24 month policy window. Key risks are execution and funding: recruiting clinicians is constrained by national training capacity and union/credentialing pushback, so misses would blunt demand for equipment and software and could trigger political backlash ahead of the next election cycle. Watch near-term catalysts — procurement RFPs, incremental billing-code changes for virtual care, and publicized vacancy/hiring metrics — which will move expectations on who captures the incremental spend over quarters, not days. For monitoring, track provincial tender notices, telehealth claim volumes, OR block-time utilization, and nurse practitioner credential approvals; those metrics will confirm whether the plan is demand-creating (buy-side) or largely headline-driven (fade). Position sizing should reflect high policy execution risk but clear multi-year structural optionality for platform and staffing plays.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.15

Key Decisions for Investors

  • Long WELL Health Technologies (WELL.TO) — 12–18 month horizon. Rationale: scale in Canadian virtual-care/EMR rollouts; use a 6–12 month call spread to cap downside. Target +30–40% on broader provincial rollouts; downside is execution and municipal procurement delays.
  • Long TELUS (T.TO) — 6–12 month horizon. Rationale: incumbent telco with integrated virtual-care offerings that can capture recurring billing; buy shares or 9–12 month calls. Reward: steady revenue growth and multiple expansion if telehealth adoption accelerates; risk: regulatory limits on billable virtual visits or margin pressure in core business.
  • Long AMN Healthcare (AMN) or Cross Country Healthcare (CCRN) — 3–9 month horizon. Rationale: near-term benefit from locum and temp staffing as provinces attempt to hit hiring targets; buy equity or short-dated calls. Reward: outsized revenue upside if hiring surges; risk: wage inflation and slower-than-expected hiring reducing margin upside.
  • Long Stryker (SYK) or Zimmer Biomet (ZBH) — 12–24 month horizon via call spreads. Rationale: incremental OR utilization and diagnostic throughput lift procedure-related consumables and implants over time. Reward: 10–25% upside if multi-province capacity programs follow; risk: aggressive provincial procurement/pricing negotiations compress ASPs.